Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Delix Therapeutics
Recent news which mentions Delix Therapeutics
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
September 09, 2024
Tickers
NEWS
Tags
Psilocybin
Psilera
Top Stories
From
Benzinga
Delix's Non-Hallucinogen Completes Safe Administration To First Clinical Trial Cohort
June 20, 2023
Tags
Markets
Management
Cannabis
From
Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
May 09, 2023
Tags
News
Psychedelics
Psychoplastogens
From
Benzinga
Delix: Elucidating How Psychedelics Actually Induce Neuroplasticity Vs. SSRIs
February 17, 2023
Tags
Market News
Guidance
Global
From
Benzinga
Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
February 16, 2023
Tickers
PSYCF
Tags
Top Stories
Delix Therapeutics
Benzinga
From
Benzinga
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
September 14, 2022
Tickers
DMTTF
NUMIF
TRYPF
Tags
Delix Therapeutics
Benzinga
Nature Biotechnology
From
Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
Tickers
ATAI
AWKNF
CYBN
FTRP
Tags
psychedelics
AWKNF
Cannabis
From
Benzinga
Delix Therapeutics Raises $30M In Convertible Note Financing, Will Enhance Drug Development Program
January 11, 2022
Tags
psychedelics
Market News
Cannabis
From
Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Tickers
ATAI
NVMDF
Tags
ATAI Life Sciences
Delix Therapeutics
Government
From
Benzinga
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
Tickers
BRAXF
FTRP
MCURF
NVMDF
Tags
Markets
Cannabis
MCURF
From
Benzinga
'Psychedelics Without Hallucinations': Concept Get Closer To Human Trials With $70M Funding
September 27, 2021
Tags
Market News
Cannabis
Benzinga
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.